CELCUITY INC. Operating Income
CELCUITY INC. (CELC) reported Operating Income of -$66.12 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Income Statement
us-gaap:OperatingIncomeLoss · last filed 2026-08-13
- CELCUITY INC. operating income (loss) for the quarter ending 2026-06-30 was -$66.12M.
- CELCUITY INC. operating income (loss) for the quarter ending 2026-03-31 was -$50.51M.
- CELCUITY INC. operating income (loss) for the quarter ending 2025-12-31 was -$49.20M.
- CELCUITY INC. operating income (loss) for the quarter ending 2025-09-30 was -$42.85M.
- CELCUITY INC. operating income (loss) for fiscal 2025 was -$172.19M.
- CELCUITY INC. operating income (loss) for fiscal 2024 was -$113.27M.
- CELCUITY INC. operating income (loss) for fiscal 2023 was -$66.23M.
- CELCUITY INC. operating income (loss) for fiscal 2022 was -$39.39M.
| Period end | Operating Income (Loss) 3 month | Operating Income (Loss) 3 month as first filed | Operating Income (Loss) 6 month | Operating Income (Loss) 6 month as first filed | Operating Income (Loss) 9 month | Operating Income (Loss) 9 month as first filed | Operating Income (Loss) 12 month | Operating Income (Loss) 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$66.12M 10-Q · filed 2026-08-13 | -$116.63M 10-Q · filed 2026-08-13 | -$165.83M derived: sum of 3 quarters · filed 2026-08-13 | -$208.68M derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2026-03-31 | -$50.51M 10-Q · filed 2026-05-14 | -$99.71M derived: sum of 2 quarters · filed 2026-05-14 | -$142.56M derived: sum of 3 quarters · filed 2026-05-14 | -$186.57M derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2025-12-31 | -$49.20M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26 | -$92.05M derived: sum of 2 quarters · filed 2026-03-26 | -$136.06M derived: sum of 3 quarters · filed 2026-08-13 | -$172.19M 10-K · filed 2026-03-26 | ||||
| 2025-09-30 | -$42.85M 10-Q · filed 2025-11-13 | -$86.86M derived: sum of 2 quarters · filed 2026-08-13 | -$122.99M 10-Q · filed 2025-11-13 | -$159.42M derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2025-06-30 | -$44.01M 10-Q · filed 2026-08-13 | -$80.14M 10-Q · filed 2026-08-13 | -$116.57M derived: sum of 3 quarters · filed 2026-08-13 | -$146.63M derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2025-03-31 | -$36.13M 10-Q · filed 2026-05-14 | -$72.56M derived: sum of 2 quarters · filed 2026-05-14 | -$102.62M derived: sum of 3 quarters · filed 2026-05-14 | -$126.91M derived: sum of 4 quarters · filed 2026-05-14 | ||||
| 2024-12-31 | -$36.43M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26 | -$66.49M derived: sum of 2 quarters · filed 2026-03-26 | -$90.77M derived: sum of 3 quarters · filed 2026-03-26 | -$113.27M 10-K · filed 2026-03-26 | -$113.27M 10-K · filed 2025-03-31 | |||
| 2024-09-30 | -$30.06M 10-Q · filed 2025-11-13 | -$30.06M 10-Q · filed 2024-11-14 | -$54.34M derived: sum of 2 quarters · filed 2025-11-13 | -$76.84M 10-Q · filed 2025-11-13 | -$76.84M 10-Q · filed 2024-11-14 | -$96.57M derived: sum of 4 quarters · filed 2025-11-13 | ||
| 2024-06-30 | -$24.28M 10-Q · filed 2025-08-14 | -$24.28M 10-Q · filed 2024-08-14 | -$46.78M 10-Q · filed 2025-08-14 | -$46.78M 10-Q · filed 2024-08-14 | -$66.51M derived: sum of 3 quarters · filed 2025-08-14 | -$85.40M derived: sum of 4 quarters · filed 2025-08-14 | ||
| 2024-03-31 | -$22.49M 10-Q · filed 2025-05-15 | -$22.49M 10-Q · filed 2024-05-15 | -$42.22M derived: sum of 2 quarters · filed 2025-05-15 | -$61.12M derived: sum of 3 quarters · filed 2025-05-15 | -$76.18M derived: sum of 4 quarters · filed 2025-05-15 | |||
| 2023-12-31 | -$19.73M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | -$38.63M derived: sum of 2 quarters · filed 2025-03-31 | -$53.68M derived: sum of 3 quarters · filed 2025-03-31 | -$66.23M 10-K · filed 2025-03-31 | ||||
| 2023-09-30 | -$18.90M 10-Q · filed 2024-11-14 | -$33.95M derived: sum of 2 quarters · filed 2024-11-14 | -$46.50M 10-Q · filed 2024-11-14 | -$58.14M derived: sum of 4 quarters · filed 2024-11-14 | ||||
| 2023-06-30 | -$15.06M 10-Q · filed 2024-08-14 | -$27.60M 10-Q · filed 2024-08-14 | -$39.24M derived: sum of 3 quarters · filed 2024-08-14 | -$49.89M derived: sum of 4 quarters · filed 2024-08-14 | ||||
| 2023-03-31 | -$12.55M 10-Q · filed 2024-05-15 | -$24.19M derived: sum of 2 quarters · filed 2024-05-15 | -$34.83M derived: sum of 3 quarters · filed 2024-05-15 | -$44.43M derived: sum of 4 quarters · filed 2024-05-15 | ||||
| 2022-12-31 | -$11.64M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-27 | -$22.28M derived: sum of 2 quarters · filed 2024-03-27 | -$31.88M derived: sum of 3 quarters · filed 2024-03-27 | -$39.39M 10-K · filed 2024-03-27 | ||||
| 2022-09-30 | -$10.64M 10-Q · filed 2023-11-13 | -$20.24M derived: sum of 2 quarters · filed 2023-11-13 | -$27.75M 10-Q · filed 2023-11-13 | -$34.07M derived: sum of 4 quarters · filed 2023-11-13 | ||||
| 2022-06-30 | -$9.60M 10-Q · filed 2023-08-11 | -$17.11M 10-Q · filed 2023-08-11 | -$23.43M derived: sum of 3 quarters · filed 2023-08-11 | -$29.03M derived: sum of 4 quarters · filed 2023-08-11 | ||||
| 2022-03-31 | -$7.51M 10-Q · filed 2023-05-15 | -$13.83M derived: sum of 2 quarters · filed 2023-05-15 | -$19.43M derived: sum of 3 quarters · filed 2023-05-15 | -$33.07M derived: sum of 4 quarters · filed 2023-05-15 | ||||
| 2021-12-31 | -$6.32M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-23 | -$11.92M derived: sum of 2 quarters · filed 2023-03-23 | -$25.56M derived: sum of 3 quarters · filed 2023-03-23 | -$28.36M 10-K · filed 2023-03-23 | ||||
| 2021-09-30 | -$5.60M 10-Q · filed 2022-11-10 | -$19.24M derived: sum of 2 quarters · filed 2022-11-10 | -$22.04M 10-Q · filed 2022-11-10 | -$24.59M derived: sum of 4 quarters · filed 2022-11-10 | ||||
| 2021-06-30 | -$13.64M 10-Q · filed 2022-08-12 | -$16.44M 10-Q · filed 2022-08-12 | -$18.99M derived: sum of 3 quarters · filed 2022-08-12 | -$21.47M derived: sum of 4 quarters · filed 2022-08-12 | ||||
| 2021-03-31 | -$2.79M 10-Q · filed 2022-05-16 | -$5.34M derived: sum of 2 quarters · filed 2022-05-16 | -$7.82M derived: sum of 3 quarters · filed 2022-05-16 | -$10.04M derived: sum of 4 quarters · filed 2022-05-16 | ||||
| 2020-12-31 | -$2.55M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-23 | -$5.03M derived: sum of 2 quarters · filed 2022-03-23 | -$7.25M derived: sum of 3 quarters · filed 2022-03-23 | -$9.56M 10-K · filed 2022-03-23 | ||||
| 2020-09-30 | -$2.48M 10-Q · filed 2021-11-09 | -$4.69M derived: sum of 2 quarters · filed 2021-11-09 | -$7.00M 10-Q · filed 2021-11-09 | -$8.90M derived: sum of 4 quarters · filed 2021-11-09 | ||||
| 2020-06-30 | -$2.21M 10-Q · filed 2021-08-11 | -$4.52M 10-Q · filed 2021-08-11 | -$6.42M derived: sum of 3 quarters · filed 2021-08-11 | -$8.51M derived: sum of 4 quarters · filed 2021-08-11 | ||||
| 2020-03-31 | -$2.31M 10-Q · filed 2021-05-10 | -$4.21M derived: sum of 2 quarters · filed 2021-05-10 | -$6.30M derived: sum of 3 quarters · filed 2021-05-10 | -$8.14M derived: sum of 4 quarters · filed 2021-05-10 | ||||
| 2019-12-31 | -$1.90M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-16 | -$3.99M derived: sum of 2 quarters · filed 2021-02-16 | -$5.83M derived: sum of 3 quarters · filed 2021-02-16 | -$7.81M 10-K · filed 2021-02-16 | ||||
| 2019-09-30 | -$2.09M 10-Q · filed 2020-11-09 | -$3.93M derived: sum of 2 quarters · filed 2020-11-09 | -$5.91M 10-Q · filed 2020-11-09 | -$7.86M derived: sum of 4 quarters · filed 2020-11-09 | ||||
| 2019-06-30 | -$1.84M 10-Q/A · filed 2020-08-11 | -$3.82M 10-Q/A · filed 2020-08-11 | -$5.77M derived: sum of 3 quarters · filed 2020-08-11 | -$7.74M derived: sum of 4 quarters · filed 2020-08-11 | ||||
| 2019-03-31 | -$1.97M 10-Q · filed 2020-05-07 | -$3.93M derived: sum of 2 quarters · filed 2020-05-07 | -$5.90M derived: sum of 3 quarters · filed 2020-05-07 | -$7.83M derived: sum of 4 quarters · filed 2020-05-07 | ||||
| 2018-12-31 | -$1.95M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-13 | -$3.93M derived: sum of 2 quarters · filed 2020-03-13 | -$5.86M derived: sum of 3 quarters · filed 2020-03-13 | -$7.93M 10-K · filed 2020-03-13 | ||||
| 2018-09-30 | -$1.98M 10-Q · filed 2019-11-07 | -$3.91M derived: sum of 2 quarters · filed 2019-11-07 | -$5.98M 10-Q · filed 2019-11-07 | -$7.81M derived: sum of 4 quarters · filed 2019-11-07 | ||||
| 2018-06-30 | -$1.93M 10-Q · filed 2019-08-08 | -$4.01M 10-Q · filed 2019-08-08 | -$5.83M derived: sum of 3 quarters · filed 2019-08-08 | -$7.36M derived: sum of 4 quarters · filed 2019-08-08 | ||||
| 2018-03-31 | -$2.08M 10-Q · filed 2019-05-07 | -$3.90M derived: sum of 2 quarters · filed 2019-05-07 | -$5.43M derived: sum of 3 quarters · filed 2019-05-07 | -$7.04M derived: sum of 4 quarters · filed 2019-05-07 | ||||
| 2017-12-31 | -$1.82M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-01 | -$3.35M derived: sum of 2 quarters · filed 2019-03-01 | -$4.96M derived: sum of 3 quarters · filed 2019-03-01 | -$5.95M 10-K · filed 2019-03-01 | ||||
| 2017-09-30 | -$1.53M 10-Q · filed 2018-11-13 | -$3.14M derived: sum of 2 quarters · filed 2018-11-13 | -$4.13M 10-Q · filed 2018-11-13 | -$5.04M derived: sum of 4 quarters · filed 2018-11-13 | ||||
| 2017-06-30 | -$1.61M 10-Q · filed 2018-08-09 | -$2.60M 10-Q · filed 2018-08-09 | -$3.51M derived: sum of 3 quarters · filed 2018-08-09 | -$4.38M derived: sum of 4 quarters · filed 2018-08-09 | ||||
| 2017-03-31 | -$993.91K 10-Q · filed 2018-05-14 | -$1.90M derived: sum of 2 quarters · filed 2018-05-14 | -$2.78M derived: sum of 3 quarters · filed 2018-05-14 | |||||
| 2016-12-31 | -$907.41K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-15 | -$1.78M derived: sum of 2 quarters · filed 2018-03-15 | -$3.33M 10-K · filed 2018-03-15 | |||||
| 2016-09-30 | -$877.54K 10-Q · filed 2017-12-01 | -$2.42M 10-Q · filed 2017-12-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| BIODESIX INC (BDSX) | United States | $0.312B |